China's rapidly growing economy, highly motivated and qualified personnel in conjunction with low costs as well as government incentives can be seen as the driving force for major global players to invest in China. China is also increasingly being seen as an attractive R&D location and pharmaceutical market.
In addition to various projects executed, FESTEL CAPITAL has also investigated the opportunities and risks for foreign pharma and chemical companies with regard to setting up own R&D centres and investing in China.
Investment Strategies and Execution in China
Pharmaceutical Production in China
R&D Activities of Chemical and Pharmceutical Companies in China
Chemical/Lifescience Related Venture Capital Opportunities in China
